NCT02792751

Brief Summary

Objective Endoscopic Retrograde Cholangiopancreatography (ERCP) is performed for resolving cholestasis by sphincterotomy and/or stone extraction and is done with deep sedation or general anesthesia. The investigators primary outcome was to evaluate the effects of the depth of anesthesia on oxidative stres provided via Bispectral Index (BIS) monitorisation during the ERCP procedure by analyzing the biochemical parameters. And their secondary outcome was the effects of anesthesia depth on propofol consumption and postoperative sedation status.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 8, 2016

Completed
Last Updated

January 24, 2017

Status Verified

May 1, 2016

Enrollment Period

11 months

First QC Date

May 27, 2016

Last Update Submit

January 23, 2017

Conditions

Keywords

Depth of anesthesiaBISERCPPositive Regulation

Outcome Measures

Primary Outcomes (1)

  • Effects of BIS on oxidative stress

    The investigators aimed to investigate the effects of anesthesia with monitoring the depth of anesthesia using BIS on oxidative stres by measuring the total oxidant status (TAS) and total antioxidant status (TOS) , propofol consumption, and postoperative recovery during ERCP procedures in this study.

    one day

Study Arms (2)

Group R (Ramsey)=25 patients

ACTIVE COMPARATOR

Propofol infusion was administered to provide Ramsey Sedation Scale 3-4 in Group R

Other: Ramsey Sedation Scale

Group B (BIS)=25 patients

EXPERIMENTAL

Propofol infusion was given to maintain the Bispectral index monitorisation (BIS) levels between 60 and 85 in Group B.

Device: Bispectral Index Monitorisation (BIS)

Interventions

Standard monitoring was performed with electrocardiography, pulse oximetry and non invasive blood pressure. Additionally, Bispectral index (Aspect Medical Systems, Natica, MA) electrodes were connected to Group B patients

Group B (BIS)=25 patients

Propofol administration was done to keep the Ramsey Sedation scale of 3 or 4

Group R (Ramsey)=25 patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with American Society of Anesthesiologists physical status I-II
  • Patients undergoing ERCP procedures

You may not qualify if:

  • uncontrolled comorbidities (hypertension, diabetes mellitus, kidney-liver failure)
  • difficulty in communication (language problems, such as deafness)
  • who are allergic to the drugs used
  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2016

First Posted

June 8, 2016

Study Start

May 1, 2014

Primary Completion

April 1, 2015

Study Completion

October 1, 2015

Last Updated

January 24, 2017

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

There is no plan to share data